CDB-4124 (Proellex, Progenta) is a selective progesterone receptor modulator.

Fontolizumab (marketed under the trade name HuZAF) is a humanized monoclonal antibody which is used as an immunosuppressive drug to treat Crohn's disease.

Oxamniquine is an anthelmintic with schistosomicidal activity against Schistosoma mansoni, but not against other Schistosoma spp. Oxamniquine is a potent single-dose agent for treatment of Schistosoma mansoni infection in man and it causes worms to shift from the mesenteric veins to the liver where the male worms are retained; the female worms return to the mesentery, but can no longer release eggs.

Palifermin (Kepivance, Amgen) is a human recombinant keratinocyte growth factor (KGF) produced in Escherichia coli. When patients with blood cancers undergo high dose chemotherapy and radiation to undergo bone marrow transplant, they usually get severe oral mucositis. Palifermin binds to epithelial cell-surface receptors and stimulates epithelial cell proliferation, differentiation, and upregulation of cytoprotective mechanisms. It reduces the incidence and duration of severe oral mucitis by protecting those cells and stimulating the growth of new epithelial cells to build up the mucosal barrier.

Bazedoxifene is a selective estrogen receptor modulator (SERM), developed by Wyeth Pharmaceuticals, undergoing clinical evaluation for the prevention and treatment of postmenopausal osteoporosis. It is currently in the early phases of review by the United States' Food and Drug Administration. When approved, bazedoxifene is to be sold by Wyeth under the tradename Viviant. Bazedoxifene's combination with conjugated estrogens, Aprela, is currently undergoing Phase III studies.

Lead sulfide (also spelled sulphide, see Sulfur#Spelling) is a chemical compound , most often purified from the mineral galena. PbS, PbSe and PbTe lead salts are semiconductors of the IV-VI family. Lead sulfide is toxic due to the lead content, see lead poisoning.

Ceftibuten is a third-generation cephalosporin antibiotic. It is an orally-administered agent, with 2 dosage forms, capsule or oral suspension. It is marketed by Shionogi USA under the trade name Cedax

Cefquinome (4GC) is a fourth generation cephalosporin with pharmacological and antibacterial properties valuable in the treatment of coliform mastitis and other infections. It is used in the treatment of both humans and animals. According to the Washington Post, it is used as a last line of defence to keep humans alive.

Bectumomab (marketed under the trade name LymphoScan) is a mouse monoclonal antibody which is used to treat non-Hodgkin's lymphoma. It has a radioisotope, technetium (99m TC) which is added.

Ertumaxomab (marketed under the brand name Rexomun) is a rat-murine hybrid monoclonal antibody which is used to treat some cancers.